CAFICRESTAT

UNII:	E8I3O45DDU
Formula:	C₁₇H₁₀F₃N₅O₃S
Preferred Substance Name:	CAFICRESTAT
InChIKey:	YRGPAXAVTDMKDK-UHFFFAOYSA-N

1355612-71-3
(8-OXO-7-((5-(TRIFLUOROMETHYL)-1,3-BENZOTHIAZOL-2-YL)METHYL)-7,8-DIHYDROPYRAZINO(2,3-D)PYRIDAZIN-5-YL)ACETIC ACID
2-(8-OXO-7-((5-(TRIFLUOROMETHYL)BENZO(D)THIAZOL-2-YL)METHYL)-7,8-DIHYDROPYRAZINO(2,3-D)PYRIDAZIN-5-YL) ACETIC ACID
7,8-DIHYDRO-8-OXO-7-((5-(TRIFLUOROMETHYL)-2-BENZOTHIAZOLYL)METHYL)PYRAZINO(2,3-D)PYRIDAZINE-5-ACETIC ACID
ALDOSE REDUCTASE-IN-1
AT 001 [WHO-DD]
AT001
AT-001
CAFICRESTAT [INN]
CAFICRESTAT [USAN]
PYRAZINO(2,3-D)PYRIDAZINE-5-ACETIC ACID, 7,8-DIHYDRO-8-OXO-7-((5-(TRIFLUOROMETHYL)-2-BENZOTHIAZOLYL)METHYL)-

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CAFICRESTAT

Synonyms and Mappings

Resources